Skip to main content

Beta-Interferons

  • Reference work entry
  • First Online:
Encyclopedia of Clinical Neuropsychology
  • 3 Accesses

Synonyms

Avonex®; Betaseron®; Rebif®

Definition

Interferon β is a disease-modifying drug currently indicated for treatment of relapsing forms of multiple sclerosis. Its mechanism of action is complex and is presumed to inhibit immune system T-cell activation and migration into the central nervous system as well as modulate the action of some pro-inflammatory proteins (cytokines). There are three FDA approved beta interferons available in the US - Avonex® (INF-β1a), Betaseron® (INF-β1b), and Rebif® (INF-β1a). These medications are administered via injection, and each has been shown to reduce the frequency of MS relapses, reduce MRI evidence of brain lesions, and possibly reduce disability progression.

Cross-References

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,099.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Readings

  • National Clinical Advisory Board of the National Multiple Sclerosis Society. (2007). Disease management consensus statement. Retrieved 15 Feb 2010, from http://www.nationalmssociety.org/download.aspx?id=8.

  • Noseworthy, J., Miller, D., & Compston, A. (2006). Disease-modifying treatments in multiple sclerosis. In A. Compston, C. Confavreux, H. Lassman, I. McDonald, D. Miller, J. Noseworthy, et al. (Eds.), McAlpine’s multiple sclerosis (4th ed., pp. 729–802). Philadelphia: Elsevier.

    Chapter  Google Scholar 

  • Zhang, J., Hutton, G., & Zang, Y. (2002). A comparison of the mechanisms of action of interferon beta and glatiramer acetate in the treatment of multiple sclerosis. Clinical Therapeutics, 24, 1998–2021.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathleen L. Fuchs .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Fuchs, K.L. (2018). Beta-Interferons. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-57111-9_517

Download citation

Publish with us

Policies and ethics